Anti-CD19 chimeric antigen receptor: Phase I data

Data from 19 patients with various subtypes of DLBCL in an NIH-funded

Read the full 123 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE